GEN-MKT-18-7897-A
Jan 2, 2019 | Biopharma, Blogs | 0 comments
As interest in N-glycan analysis grows within the biopharma industry, innovation continues allowing analyses to be done in less time with fewer and less tedious, sample preparation steps. One of these recent innovations was the release of the SCIEX Fast Glycan Technology which offers a simplified 60-minute sample prep, 5-minute separations, and automatic glycan identification. But what happens when you have an unknown peak in your sample, or if you need to confirm the structural identity of a critical glycan species? Well, developments in N-glycan analysis has continued with new methods for N-Glycan sequencing which provide complete structural elucidation in as little as 1 hour.
Having Problems With Glycan Sequencing?Previously, carbohydrate sequencing was a tedious and time-consuming manual process. It required either consecutive addition of sequencing exoglycosidase enzymes to a single vial, which could take up to a week, or arrays of enzymes in multiple vials and parallel processing of samples which could still take a full day.
Combatting Glycan Sequencing Challenges: To break through the problems associated with older sequencing methods, two different approaches have been developed that significantly decrease manual steps and reduces the analysis time from 1–5 days to 1–2 hours. These are both semi- and fully-automated methods which can be used on your existing PA 800 Plus Pharmaceutical Analysis System together with the award-winning Fast Glycan Technology to give you the reliable data you need faster.
Differences Between Semi- and Fully- Automated Methods: The semi-automated, array-based sequencing requires only 1 hour (including reaction times, digestions, and the CE-LIF separations). However, manual pre-mixing of the enzyme mixtures is required, as well as a higher concentration of your IgG1 sample. The fully automated workflow does not require any pre-analysis of reaction arrays, but due to its serial nature, the total sequencing time was just over 2 hours. The flexibility to choose between these methods means that you can optimize your analysis for speed or ease of use depending on your needs.
If you’re interested in learning more about the new automated N-glycan sequencing methods, fill out the form on the right to watch the webinar, Sequence Your Biopharma N-Glycans in as Little as 1 Hour.
Resources:
It is no secret that (bio)pharmaceutical research and development is complex, both scientific and regulatory processes. Here is an overview of just some of the ways SCIEX is working to support these challenges.
In a recent webinar, available on demand, scientists Luiza Chrojan and Ryan Hylands from Pharmaron, provided insights into the deployment of capillary gel electrophoresis (CGE) within cell and gene therapy. Luiza and Ryan shared purity data on plasmids used for adeno-associated virus (AAV) manufacturing and data on AAV genome integrity, viral protein (VP) purity and VP ratios using the BioPhase 8800 system.
Last year, Technology Networks hosted two webinars that featured groundbreaking research utilizing SWATH DIA (data-independent acquisition) for exposomics and metabolomics. Researchers Dr. Vinicius Verri Hernandes from the University of Vienna and Dr. Cristina Balcells from Imperial College London (ICL) demonstrated how a DIA approach can be successfully implemented in small molecule analysis using the ZenoTOF 7600 system. Their innovative approaches highlight the potential of SWATH DIA to enhance the detection and analysis of chemical exposures and metabolites, paving the way for new insights into environmental health and disease mechanisms.
Posted by
You must be logged in to post a comment.
Share this post with your network